Paper1111790
Bromocriptine treatment of acromegaly.
Thorner MO and 8 others. Br Med J, 1975. Cited by 197 papers, by iCite.
Cite this record
ConductScience Library. Bromocriptine treatment of acromegaly. Papers, record 1111790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1111790
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acromegaly | Major topic |
| Ergot Alkaloids | Major topic |
| Adult | |
| Aged | |
| Blood Glucose | |
| Bromine | |
| Circadian Rhythm | |
| Female | |
| Glucagon | |
| Growth Hormone | |
| Humans | |
| Hydroxyproline | |
| Insulin | |
| Male | |
| Middle Aged | |
| Sweating |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4672085 | [Galactorrhea in the woman]. | Schweiz Rundsch Med Prax | 1972 | https://conductscience.org/library/papers/4672085 | PubMed |
| 2 | 5752992 | [2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]. | Experientia | 1968 | https://conductscience.org/library/papers/5752992 | PubMed |
| 3 | 4722381 | Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility. | Am J Obstet Gynecol | 1973 | https://conductscience.org/library/papers/4722381 | PubMed |
| 4 | 5093772 | Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release. | J Clin Endocrinol Metab | 1971 | https://conductscience.org/library/papers/5093772 | PubMed |
| 5 | 4125377 | Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. | Lancet | 1973 | https://conductscience.org/library/papers/4125377 | PubMed |
| 6 | 4139406 | Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. | Lancet | 1974 | https://conductscience.org/library/papers/4139406 | PubMed |
| 7 | 4132421 | Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. | Lancet | 1974 | https://conductscience.org/library/papers/4132421 | PubMed |
| 8 | 4394360 | Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine. | Nature | 1970 | https://conductscience.org/library/papers/4394360 | PubMed |
| 9 | 4393264 | Stimulatory effect of exogenous catecholamines on plasma HGH concentrations in presence of beta adrenergic blockade. | Metabolism | 1970 | https://conductscience.org/library/papers/4393264 | PubMed |
| 10 | 4351250 | Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report. | Schweiz Med Wochenschr | 1973 | https://conductscience.org/library/papers/4351250 | PubMed |
| 11 | 4624031 | Clinical neuropharmacology of hypothalamic releasing factors. | N Engl J Med | 1972 | https://conductscience.org/library/papers/4624031 | PubMed |
| 12 | 4600593 | Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. | Br Med J | 1974 | https://conductscience.org/library/papers/4600593 | PubMed |
| 13 | 4796692 | A comparative study on the metabolism of human insulin and porcine proinsulin in man. | Clin Sci Mol Med | 1973 | https://conductscience.org/library/papers/4796692 | PubMed |
| 14 | 4715294 | The effect of a single dose of L-dopa on pituitary hormones in acromegaly, obesity, and in normal subjects. | J Clin Endocrinol Metab | 1973 | https://conductscience.org/library/papers/4715294 | PubMed |
| 15 | 4678204 | Immunoreactive growth hormone in human urine. | Acta Endocrinol (Copenh) | 1972 | https://conductscience.org/library/papers/4678204 | PubMed |
| 16 | 5061778 | The effect of L-dopa on plasma growth hormone, insulin, and thyroxine. | J Clin Endocrinol Metab | 1972 | https://conductscience.org/library/papers/5061778 | PubMed |
| 17 | 4634493 | Inhibitory effect of L-Dopa on GH release in acromegalic patients. | J Clin Endocrinol Metab | 1972 | https://conductscience.org/library/papers/4634493 | PubMed |
| 18 | 4864804 | Determination of hydroxyproline. | Clin Chim Acta | 1967 | https://conductscience.org/library/papers/4864804 | PubMed |
| 19 | 5105218 | Plasma prolactin activity in inappropriate lactation. | Br Med J | 1971 | https://conductscience.org/library/papers/5105218 | PubMed |
| 20 | 4217900 | Radioimmunoassay of human prolactin. | Proc R Soc Med | 1973 | https://conductscience.org/library/papers/4217900 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35698232 | Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells. | Orphanet J Rare Dis | 2022 | https://conductscience.org/library/papers/35698232 | PubMed |
| 33910017 | A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. | Cell Rep | 2021 | https://conductscience.org/library/papers/33910017 | PubMed |
| 27604463 | Repositioning of bromocriptine for treatment of acute myeloid leukemia. | J Transl Med | 2016 | https://conductscience.org/library/papers/27604463 | PubMed |
| 24532103 | Cabergoline treatment in acromegaly: pros. | Endocrine | 2014 | https://conductscience.org/library/papers/24532103 | PubMed |
| 22216496 | The cardiovascular effects of bromocriptine in Parkinsonism. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/22216496 | PubMed |
| 18163213 | Management of acromegaly: is there a role for primary medical therapy? | Rev Endocr Metab Disord | 2008 | https://conductscience.org/library/papers/18163213 | PubMed |
| 15301564 | Pharmacological therapy for acromegaly: a critical review. | Drugs | 2004 | https://conductscience.org/library/papers/15301564 | PubMed |
| 11761430 | Acromegaly: historical perspectives and current therapy. | J Neurooncol | 2001 | https://conductscience.org/library/papers/11761430 | PubMed |
| 11081147 | Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child. | Pituitary | 2000 | https://conductscience.org/library/papers/11081147 | PubMed |
| 9413808 | Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients. | J Endocrinol Invest | 1997 | https://conductscience.org/library/papers/9413808 | PubMed |
| 7514973 | Acromegaly. Recognition and treatment. | Drugs | 1994 | https://conductscience.org/library/papers/7514973 | PubMed |
| 7427100 | Bromocriptine as sole treatment for acromegaly. | Br Med J | 1980 | https://conductscience.org/library/papers/7427100 | PubMed |
| 7027229 | Bromocriptine therapy in acromegaly. A long-term review of 35 cases. | Postgrad Med J | 1981 | https://conductscience.org/library/papers/7027229 | PubMed |
| 6993548 | Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients. | J Endocrinol Invest | 1980 | https://conductscience.org/library/papers/6993548 | PubMed |
| 6992920 | Spontaneous hypoglycaemia in active acromegaly and its response to bromocriptine. | Br Med J | 1980 | https://conductscience.org/library/papers/6992920 | PubMed |
| 6992131 | Effect of bromocriptine on maturity onset diabetes. | Postgrad Med J | 1980 | https://conductscience.org/library/papers/6992131 | PubMed |
| 6284830 | Long term bromocriptine therapy in Cushing's disease. | J Endocrinol Invest | 1982 | https://conductscience.org/library/papers/6284830 | PubMed |
| 6140273 | Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6140273 | PubMed |
| 6104974 | Neuroendocrine markers of CNS drug effects. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6104974 | PubMed |
| 3519242 | Bromocriptine in the treatment of hypertension. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3519242 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| GH1 | 2688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1111790
GET https://conductscience.org/api/papers/v1/1111790/cited_by?page=2